| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | replication fork processing | 8.89e-06 | 52 | 52 | 4 | GO:0031297 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 1.58e-05 | 60 | 52 | 4 | GO:0045005 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 1.61e-05 | 324 | 52 | 7 | GO:0006302 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 1.01e-03 | 17 | 52 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 1.01e-03 | 17 | 52 | 2 | PS51059 | |
| Domain | PARP | 1.01e-03 | 17 | 52 | 2 | PF00644 | |
| Domain | - | 1.01e-03 | 17 | 52 | 2 | 3.90.228.10 | |
| Domain | Frizzled_dom | 2.02e-03 | 24 | 52 | 2 | IPR020067 | |
| Domain | WGR_domain | 2.02e-03 | 24 | 52 | 2 | IPR008893 | |
| Domain | FZ | 2.02e-03 | 24 | 52 | 2 | PS50038 | |
| Domain | Fz | 2.02e-03 | 24 | 52 | 2 | PF01392 | |
| Domain | BRCT_dom | 2.74e-03 | 28 | 52 | 2 | IPR001357 | |
| Domain | Kinase-like_dom | 3.81e-03 | 542 | 52 | 6 | IPR011009 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.31e-08 | 332 | 52 | 8 | 32786267 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SCYL2 PARP1 KIF23 FAM193A ARFGAP1 EIF4G2 TXNDC9 STIP1 NPLOC4 PCNT ZC3HAV1 | 1.09e-07 | 934 | 52 | 11 | 33916271 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 3.05e-07 | 444 | 52 | 8 | 34795231 | |
| Pubmed | 3.43e-07 | 451 | 52 | 8 | 36168627 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A KIF23 SETX TRPM7 PHF3 SVIL ARFGAP1 GEN1 DDX1 ZC3HAV1 | 5.07e-07 | 861 | 52 | 10 | 36931259 |
| Pubmed | PARP1 KIF23 TSR1 PHF3 SVIL EIF4G2 PSMC3 SMARCC1 STIP1 DDX1 ZC3HAV1 | 1.89e-06 | 1247 | 52 | 11 | 27684187 | |
| Pubmed | 2.13e-06 | 399 | 52 | 7 | 37536630 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 27498558 | ||
| Pubmed | Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter. | 2.19e-06 | 2 | 52 | 2 | 18990703 | |
| Pubmed | IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors. | 2.19e-06 | 2 | 52 | 2 | 28634224 | |
| Pubmed | 2.21e-06 | 1014 | 52 | 10 | 32416067 | ||
| Pubmed | 2.69e-06 | 263 | 52 | 6 | 34702444 | ||
| Pubmed | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. | 2.81e-06 | 65 | 52 | 4 | 27453043 | |
| Pubmed | 4.54e-06 | 638 | 52 | 8 | 33239621 | ||
| Pubmed | 4.90e-06 | 453 | 52 | 7 | 29656893 | ||
| Pubmed | 5.20e-06 | 650 | 52 | 8 | 38777146 | ||
| Pubmed | 5.38e-06 | 653 | 52 | 8 | 22586326 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 28802254 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 25865228 | ||
| Pubmed | Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1. | 6.57e-06 | 3 | 52 | 2 | 22447567 | |
| Pubmed | The HSF1-PARP13-PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis. | 6.57e-06 | 3 | 52 | 2 | 29158484 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 31916449 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 21555554 | ||
| Pubmed | Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. | 6.57e-06 | 3 | 52 | 2 | 21487248 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 25793984 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 22586318 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 20186884 | ||
| Pubmed | KIF23 SVIL ARFGAP1 NFYA PSMC3 SMARCC1 E2F3 STIP1 MBD2 DDX1 ZC3HAV1 | 6.94e-06 | 1429 | 52 | 11 | 35140242 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 7.69e-06 | 316 | 52 | 6 | 31665637 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 7.74e-06 | 486 | 52 | 7 | 30940648 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 8.55e-06 | 322 | 52 | 6 | 39098523 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SCYL2 PARP1 TRPM7 PSMC3 SECISBP2 TXNDC9 STIP1 MTFR2 GEN1 PCNT ZC3HAV1 | 1.07e-05 | 1496 | 52 | 11 | 32877691 |
| Pubmed | FZD10-Gα13 signalling axis points to a role of FZD10 in CNS angiogenesis. | 1.31e-05 | 4 | 52 | 2 | 28126591 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 27643881 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 22344029 | ||
| Pubmed | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | 1.31e-05 | 4 | 52 | 2 | 23548269 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.44e-05 | 989 | 52 | 9 | 36424410 | |
| Pubmed | 2.06e-05 | 222 | 52 | 5 | 35941108 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 7716543 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PARP1 FAM111A TSR1 CLK2 PSMC3 SMARCC1 TXNDC9 STIP1 DDX1 ZC3HAV1 | 2.19e-05 | 1318 | 52 | 10 | 30463901 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.64e-05 | 588 | 52 | 7 | 38580884 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | PARP1 KIF23 ARFGAP1 EIF4G2 SMARCC1 STIP1 AKR1A1 NPLOC4 ZC3HAV1 XPO7 | 2.99e-05 | 1367 | 52 | 10 | 32687490 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 3.16e-05 | 605 | 52 | 7 | 28977666 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.26e-05 | 608 | 52 | 7 | 36089195 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 20528243 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 24349500 | ||
| Pubmed | 3.51e-05 | 615 | 52 | 7 | 31048545 | ||
| Pubmed | 3.71e-05 | 251 | 52 | 5 | 31076518 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 3.81e-05 | 420 | 52 | 6 | 28065597 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PARP1 DENND4A KIF23 TSR1 EIF4G2 PSMC3 SMARCC1 STIP1 DDX1 ZC3HAV1 | 4.25e-05 | 1425 | 52 | 10 | 30948266 |
| Pubmed | 4.25e-05 | 634 | 52 | 7 | 34591612 | ||
| Pubmed | Patterns of cell signaling pathway activation that characterize mammary development. | 4.58e-05 | 7 | 52 | 2 | 18550711 | |
| Pubmed | Elongator and codon bias regulate protein levels in mammalian peripheral neurons. | 4.58e-05 | 7 | 52 | 2 | 29497044 | |
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 14607943 | ||
| Pubmed | Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency. | 4.58e-05 | 7 | 52 | 2 | 34750509 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.93e-05 | 440 | 52 | 6 | 34244565 | |
| Pubmed | 4.97e-05 | 267 | 52 | 5 | 33417871 | ||
| Pubmed | 5.48e-05 | 660 | 52 | 7 | 32780723 | ||
| Pubmed | 5.62e-05 | 274 | 52 | 5 | 34244482 | ||
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | 6.10e-05 | 8 | 52 | 2 | 17200871 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 6.48e-05 | 678 | 52 | 7 | 30209976 | |
| Pubmed | 7.46e-05 | 149 | 52 | 4 | 25184681 | ||
| Pubmed | Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. | 7.84e-05 | 9 | 52 | 2 | 24085845 | |
| Pubmed | KIF20A/MKLP2 regulates the division modes of neural progenitor cells during cortical development. | 7.84e-05 | 9 | 52 | 2 | 30006548 | |
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 7749980 | ||
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 19289495 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 7.84e-05 | 9 | 52 | 2 | 8662091 | |
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 28628639 | ||
| Pubmed | PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. | 7.84e-05 | 9 | 52 | 2 | 15687262 | |
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 18340360 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 8.04e-05 | 954 | 52 | 8 | 36373674 | |
| Pubmed | 8.49e-05 | 708 | 52 | 7 | 39231216 | ||
| Pubmed | 9.33e-05 | 494 | 52 | 6 | 26831064 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 9.76e-05 | 724 | 52 | 7 | 36232890 | |
| Pubmed | Trim25 Is an RNA-Specific Activator of Lin28a/TuT4-Mediated Uridylation. | 9.79e-05 | 10 | 52 | 2 | 25457611 | |
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 20368359 | ||
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 12559621 | ||
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 25220058 | ||
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 24550317 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 1.08e-04 | 315 | 52 | 5 | 26777405 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 1.09e-04 | 1284 | 52 | 9 | 17353931 | |
| Pubmed | 1.17e-04 | 1007 | 52 | 8 | 34597346 | ||
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 18406329 | ||
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 18830515 | ||
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 1.20e-04 | 11 | 52 | 2 | 19664392 | |
| Pubmed | 1.38e-04 | 332 | 52 | 5 | 25693804 | ||
| Pubmed | 1.40e-04 | 333 | 52 | 5 | 36779763 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 20371502 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 1.43e-04 | 12 | 52 | 2 | 17490516 | |
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 19936734 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 1.43e-04 | 12 | 52 | 2 | 19181658 | |
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 20137308 | ||
| Pubmed | 1.45e-04 | 177 | 52 | 4 | 26206133 | ||
| Pubmed | 1.46e-04 | 1335 | 52 | 9 | 29229926 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.47e-04 | 774 | 52 | 7 | 15302935 | |
| Pubmed | 1.48e-04 | 538 | 52 | 6 | 28524877 | ||
| Pubmed | 1.51e-04 | 777 | 52 | 7 | 35844135 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.62e-04 | 1353 | 52 | 9 | 29467282 | |
| Pubmed | 1.65e-04 | 183 | 52 | 4 | 36129980 | ||
| Pubmed | 1.66e-04 | 549 | 52 | 6 | 38280479 | ||
| Interaction | SQSTM1 interactions | SCYL2 PARP1 KIF23 SETX FAM193A TSR1 ARFGAP1 EIF4G2 PSMC3 SECISBP2 STIP1 GEN1 PCNT ZC3HAV1 | 2.36e-06 | 1257 | 52 | 14 | int:SQSTM1 |
| Interaction | YWHAH interactions | DENND4A KIF23 SETX TRPM7 CLK2 PHF3 SVIL ARFGAP1 PSMC3 GEN1 DDX1 PCNT ZC3HAV1 | 3.14e-06 | 1102 | 52 | 13 | int:YWHAH |
| Interaction | TOP1 interactions | 9.64e-06 | 696 | 52 | 10 | int:TOP1 | |
| Interaction | CIT interactions | KIF23 SETX DNAH12 TSR1 SVIL EIF4G2 PSMC3 SMARCC1 SECISBP2 AKR1A1 PLS1 DDX1 MAP3K4 ZC3HAV1 | 1.23e-05 | 1450 | 52 | 14 | int:CIT |
| Interaction | SYNE3 interactions | 1.68e-05 | 444 | 52 | 8 | int:SYNE3 | |
| Interaction | SUMO2 interactions | 1.80e-05 | 591 | 52 | 9 | int:SUMO2 | |
| Interaction | HDAC1 interactions | PARP1 BRCA2 TRPM7 TSR1 NFYA PSMC3 SMARCC1 E2F3 STIP1 MBD2 DDX1 PCNT | 1.92e-05 | 1108 | 52 | 12 | int:HDAC1 |
| Interaction | CHD3 interactions | 1.99e-05 | 757 | 52 | 10 | int:CHD3 | |
| Interaction | AURKB interactions | PARP1 KIF23 SETX BRCA2 TSR1 PSMC3 SMARCC1 STIP1 DDX1 ZC3HAV1 | 2.09e-05 | 761 | 52 | 10 | int:AURKB |
| Interaction | CHD4 interactions | PARP1 KIF23 BRCA2 TSR1 EIF4G2 SMARCC1 STIP1 MBD2 DDX1 PCNT ZC3HAV1 | 2.19e-05 | 938 | 52 | 11 | int:CHD4 |
| Interaction | ANAPC2 interactions | 2.99e-05 | 234 | 52 | 6 | int:ANAPC2 | |
| Interaction | ATG16L1 interactions | SCYL2 PARP1 DENND4A FAM193A CLK2 EIF4G2 PSMC3 SMARCC1 SECISBP2 PLS1 DDX1 ZC3HAV1 | 3.04e-05 | 1161 | 52 | 12 | int:ATG16L1 |
| Interaction | ARHGAP24 interactions | 3.20e-05 | 486 | 52 | 8 | int:ARHGAP24 | |
| Interaction | TNPO3 interactions | 3.22e-05 | 237 | 52 | 6 | int:TNPO3 | |
| Interaction | NAA40 interactions | SCYL2 PARP1 KIF23 FAM193A ARFGAP1 EIF4G2 TXNDC9 STIP1 NPLOC4 PCNT ZC3HAV1 | 3.22e-05 | 978 | 52 | 11 | int:NAA40 |
| Interaction | MOB3C interactions | 3.94e-05 | 364 | 52 | 7 | int:MOB3C | |
| Interaction | YTHDF3 interactions | 3.96e-05 | 246 | 52 | 6 | int:YTHDF3 | |
| Interaction | EIF2S2 interactions | 4.05e-05 | 247 | 52 | 6 | int:EIF2S2 | |
| Interaction | BRCA1 interactions | PARP1 KIF23 SETX FAM111A BRCA2 CLK2 NFYA PSMC3 SMARCC1 STIP1 DDX1 ZC3HAV1 | 6.21e-05 | 1249 | 52 | 12 | int:BRCA1 |
| Interaction | SPAG9 interactions | 6.37e-05 | 268 | 52 | 6 | int:SPAG9 | |
| Interaction | POLR2A interactions | 6.38e-05 | 536 | 52 | 8 | int:POLR2A | |
| Interaction | USF1 interactions | 6.84e-05 | 85 | 52 | 4 | int:USF1 | |
| Interaction | IFI16 interactions | 7.85e-05 | 714 | 52 | 9 | int:IFI16 | |
| Interaction | SMC4 interactions | 8.28e-05 | 281 | 52 | 6 | int:SMC4 | |
| Interaction | EIF4G2 interactions | 9.69e-05 | 179 | 52 | 5 | int:EIF4G2 | |
| Interaction | SRSF1 interactions | 9.80e-05 | 570 | 52 | 8 | int:SRSF1 | |
| Interaction | PARP1 interactions | PARP1 KIF23 BRCA2 PHF3 SVIL ARFGAP1 EIF4G2 NFYA SMARCC1 E2F3 STIP1 PLS1 | 1.03e-04 | 1316 | 52 | 12 | int:PARP1 |
| Interaction | RNF43 interactions | 1.07e-04 | 427 | 52 | 7 | int:RNF43 | |
| Interaction | E2F6 interactions | 1.13e-04 | 185 | 52 | 5 | int:E2F6 | |
| Interaction | FUS interactions | 1.23e-04 | 757 | 52 | 9 | int:FUS | |
| Interaction | LATS1 interactions | 1.29e-04 | 440 | 52 | 7 | int:LATS1 | |
| Interaction | NIPBL interactions | 1.59e-04 | 199 | 52 | 5 | int:NIPBL | |
| Interaction | RHOT2 interactions | 1.71e-04 | 321 | 52 | 6 | int:RHOT2 | |
| Interaction | GADD45A interactions | 1.73e-04 | 108 | 52 | 4 | int:GADD45A | |
| Interaction | SMC2 interactions | 1.77e-04 | 323 | 52 | 6 | int:SMC2 | |
| Interaction | PDCD6 interactions | 1.79e-04 | 204 | 52 | 5 | int:PDCD6 | |
| Interaction | NPM1 interactions | PARP1 KIF23 FAM111A BRCA2 TSR1 EIF4G2 NFYA ANKRD18A STIP1 DDX1 ZC3HAV1 | 2.02e-04 | 1201 | 52 | 11 | int:NPM1 |
| Interaction | CLK1 interactions | 2.48e-04 | 219 | 52 | 5 | int:CLK1 | |
| Interaction | RNH1 interactions | 2.54e-04 | 220 | 52 | 5 | int:RNH1 | |
| Interaction | ISG15 interactions | 2.63e-04 | 494 | 52 | 7 | int:ISG15 | |
| Interaction | BAG1 interactions | 2.63e-04 | 494 | 52 | 7 | int:BAG1 | |
| Interaction | STAG2 interactions | 2.76e-04 | 224 | 52 | 5 | int:STAG2 | |
| Interaction | NCAPD2 interactions | 3.37e-04 | 234 | 52 | 5 | int:NCAPD2 | |
| Interaction | SSRP1 interactions | 3.43e-04 | 685 | 52 | 8 | int:SSRP1 | |
| Interaction | OTUD4 interactions | 3.50e-04 | 236 | 52 | 5 | int:OTUD4 | |
| Interaction | SLC32A1 interactions | 3.54e-04 | 11 | 52 | 2 | int:SLC32A1 | |
| Interaction | LARP4B interactions | 3.78e-04 | 240 | 52 | 5 | int:LARP4B | |
| Interaction | AP2B1 interactions | 3.83e-04 | 373 | 52 | 6 | int:AP2B1 | |
| Interaction | TP53BP1 interactions | 4.15e-04 | 533 | 52 | 7 | int:TP53BP1 | |
| Interaction | ST18 interactions | 4.24e-04 | 12 | 52 | 2 | int:ST18 | |
| Interaction | MKRN2 interactions | 4.53e-04 | 385 | 52 | 6 | int:MKRN2 | |
| Interaction | HUWE1 interactions | 4.70e-04 | 1110 | 52 | 10 | int:HUWE1 | |
| Interaction | YWHAQ interactions | DENND4A KIF23 TRPM7 CLK2 SVIL TXNDC9 ANKRD18A STIP1 RGS3 DDX1 | 4.97e-04 | 1118 | 52 | 10 | int:YWHAQ |
| Interaction | KIR3DL1 interactions | 5.00e-04 | 13 | 52 | 2 | int:KIR3DL1 | |
| Interaction | CHIC1 interactions | 5.00e-04 | 13 | 52 | 2 | int:CHIC1 | |
| Interaction | KIR2DL2 interactions | 5.00e-04 | 13 | 52 | 2 | int:KIR2DL2 | |
| Interaction | CFAP52 interactions | 5.00e-04 | 13 | 52 | 2 | int:CFAP52 | |
| Interaction | COPZ1 interactions | 5.05e-04 | 143 | 52 | 4 | int:COPZ1 | |
| Interaction | TERF2IP interactions | 5.12e-04 | 552 | 52 | 7 | int:TERF2IP | |
| Interaction | PICALM interactions | 5.74e-04 | 263 | 52 | 5 | int:PICALM | |
| Interaction | EIF4G3 interactions | 5.75e-04 | 148 | 52 | 4 | int:EIF4G3 | |
| Interaction | SIRT7 interactions | 5.93e-04 | 744 | 52 | 8 | int:SIRT7 | |
| Interaction | CDC25A interactions | 6.20e-04 | 151 | 52 | 4 | int:CDC25A | |
| Interaction | MYH9 interactions | 6.48e-04 | 754 | 52 | 8 | int:MYH9 | |
| Interaction | FZD10 interactions | 6.61e-04 | 66 | 52 | 3 | int:FZD10 | |
| Interaction | IPO5 interactions | 6.64e-04 | 414 | 52 | 6 | int:IPO5 | |
| Interaction | CEP135 interactions | 6.68e-04 | 272 | 52 | 5 | int:CEP135 | |
| Interaction | CLCN1 interactions | 6.71e-04 | 15 | 52 | 2 | int:CLCN1 | |
| Interaction | SMARCA5 interactions | 6.72e-04 | 415 | 52 | 6 | int:SMARCA5 | |
| Interaction | HMGA1 interactions | 7.07e-04 | 419 | 52 | 6 | int:HMGA1 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.68e-04 | 15 | 39 | 2 | 26 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 6.04e-04 | 17 | 39 | 2 | 684 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 6.79e-04 | 18 | 39 | 2 | 620 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | PARP1 KIF23 FAM111A BRCA2 TSR1 ROR1 NFYA PSMC3 SMARCC1 STIP1 GEN1 PLS1 XPO7 | 9.86e-07 | 1290 | 52 | 13 | M80 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP | 5.34e-06 | 127 | 52 | 5 | M40905 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 5.97e-06 | 856 | 52 | 10 | M4500 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SCYL2 PARP1 TSR1 EIF4G2 PSMC3 SMARCC1 TXNDC9 STIP1 MBD2 NPLOC4 DDX1 | 1.07e-05 | 1129 | 52 | 11 | M42508 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | KIF23 FAM111A BRCA2 TSR1 CLK2 CASP2 CCDC81 E2F3 MTFR2 GEN1 DDX1 PCNT | 1.11e-05 | 1363 | 52 | 12 | M45782 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SCYL2 PARP1 TSR1 EIF4G2 PSMC3 SMARCC1 TXNDC9 STIP1 MBD2 NPLOC4 DDX1 | 1.36e-05 | 1158 | 52 | 11 | MM1338 |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 4.67e-05 | 199 | 52 | 5 | M8974 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAC_DN | 4.67e-05 | 199 | 52 | 5 | M5403 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 | 8.09e-05 | 115 | 52 | 4 | M7995 | |
| Coexpression | FISCHER_DREAM_TARGETS | 1.09e-04 | 969 | 52 | 9 | M149 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.10e-04 | 384 | 52 | 6 | M1865 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_LB_UP | 1.12e-04 | 47 | 52 | 3 | M14744 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.41e-04 | 402 | 52 | 6 | MM1248 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | KIF23 SETX FAM111A BRCA2 TSR1 PHF3 EIF4G2 SMARCC1 STIP1 GEN1 MAP3K4 PCNT | 2.15e-09 | 532 | 49 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SETX FAM193A BRCA2 TRPM7 CLK2 PHF3 EIF4G2 SMARCC1 E2F3 STIP1 TLR7 MTFR2 GEN1 | 3.66e-06 | 1257 | 49 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SETX FAM193A BRCA2 TRPM7 CLK2 PHF3 EIF4G2 SMARCC1 E2F3 STIP1 TLR7 MTFR2 GEN1 | 1.83e-05 | 1459 | 49 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 4.87e-05 | 422 | 49 | 7 | GSM538357_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 4.87e-05 | 422 | 49 | 7 | GSM538355_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 9.44e-05 | 469 | 49 | 7 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | 9.54e-05 | 822 | 49 | 9 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 | |
| CoexpressionAtlas | e10.5_Emin_LateralNasal_top-relative-expression-ranked_500_1 | 1.09e-04 | 7 | 49 | 2 | Facebase_ST1_e10.5_Emin_LateralNasal_500_1 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 2.58e-04 | 388 | 49 | 6 | GSM538352_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.20e-04 | 259 | 49 | 5 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | 3.83e-04 | 781 | 49 | 8 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 3.84e-04 | 418 | 49 | 6 | GSM538350_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 3.89e-04 | 419 | 49 | 6 | GSM538348_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | 4.31e-04 | 795 | 49 | 8 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | 4.46e-04 | 799 | 49 | 8 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 4.55e-04 | 1241 | 49 | 10 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 4.88e-04 | 1252 | 49 | 10 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 5.67e-04 | 165 | 49 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | e9.5_MandibArch_top-relative-expression-ranked_500 | 6.07e-04 | 456 | 49 | 6 | Facebase_ST1_e9.5_MandibArch_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 6.29e-04 | 1060 | 49 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 172 | 51 | 5 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 172 | 51 | 5 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 175 | 51 | 5 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.28e-06 | 200 | 51 | 5 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.28e-06 | 200 | 51 | 5 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-05 | 146 | 51 | 4 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.18e-05 | 169 | 51 | 4 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-05 | 173 | 51 | 4 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.79e-05 | 175 | 51 | 4 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.46e-05 | 181 | 51 | 4 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-05 | 182 | 51 | 4 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.82e-05 | 184 | 51 | 4 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-05 | 190 | 51 | 4 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.59e-05 | 190 | 51 | 4 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-05 | 190 | 51 | 4 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.73e-05 | 191 | 51 | 4 | d6e158f16a183c9203c057192342e9b83e79bc89 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.73e-05 | 191 | 51 | 4 | 7cb5c6f2cf27f3503d1b313e402a7410dfe6473e | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 6.87e-05 | 192 | 51 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 193 | 51 | 4 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.01e-05 | 193 | 51 | 4 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.01e-05 | 193 | 51 | 4 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-05 | 194 | 51 | 4 | e5b81a8e52259a54a911c1c2ac932c98c988318d | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.15e-05 | 194 | 51 | 4 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.44e-05 | 196 | 51 | 4 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.44e-05 | 196 | 51 | 4 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.44e-05 | 196 | 51 | 4 | 35cc0986dc3fc4b89e960a565b8f9810b1688e09 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.44e-05 | 196 | 51 | 4 | eb8c9a4a5eb21d43ff7b25deae5896c236f669b9 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.44e-05 | 196 | 51 | 4 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.58e-05 | 197 | 51 | 4 | 2a89a724e8c15a5bb167fdad7eed31444d8c3d68 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 7.73e-05 | 198 | 51 | 4 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.73e-05 | 198 | 51 | 4 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.73e-05 | 198 | 51 | 4 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 7.73e-05 | 198 | 51 | 4 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-05 | 199 | 51 | 4 | 13ff6c26ebcc663ef8e5559ab9be99dab848abe7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 7.89e-05 | 199 | 51 | 4 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-05 | 199 | 51 | 4 | 88d130e2451e61afb710edf552e6b346b9fcfb2b | |
| ToppCell | MNPs-Dividing_Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 7.89e-05 | 199 | 51 | 4 | 5952980d0ece5d73f3e9f340c56a38b34d2f2309 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 7.89e-05 | 199 | 51 | 4 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 7.89e-05 | 199 | 51 | 4 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 7.89e-05 | 199 | 51 | 4 | dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 7.89e-05 | 199 | 51 | 4 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.89e-05 | 199 | 51 | 4 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.04e-05 | 200 | 51 | 4 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.04e-05 | 200 | 51 | 4 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.04e-05 | 200 | 51 | 4 | 9cff8be6e566f342fc8b45e93106d033b14759ee | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.04e-05 | 200 | 51 | 4 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.04e-05 | 200 | 51 | 4 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | Severe-T/NK_proliferative|Severe / Disease group and Cell class | 8.04e-05 | 200 | 51 | 4 | 4723613a9f56bff422fc98722128d57b6adf3c5d | |
| ToppCell | LAM-Myeloid-pMacrophage|LAM / Condition, Lineage and Cell class | 8.04e-05 | 200 | 51 | 4 | 7e233d037165c9d3607604aaaf0f368e266567d3 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.04e-05 | 200 | 51 | 4 | 5e1b38e2aa8901bfb2623249f7b6302e97d56ace | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 8.04e-05 | 200 | 51 | 4 | 5f2fbd789cc16af411a01c3199583888b260ae91 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.04e-05 | 200 | 51 | 4 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.04e-05 | 200 | 51 | 4 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.04e-05 | 200 | 51 | 4 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Proliferating|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.04e-05 | 200 | 51 | 4 | 9279415f5e76cb5b4e071c6582ac249b72dd694c | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 8.04e-05 | 200 | 51 | 4 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.04e-05 | 200 | 51 | 4 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | TCGA-Liver-Primary_Tumor|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.04e-05 | 200 | 51 | 4 | b667168081393433597f6ca8baeddba1d1906d40 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.04e-05 | 200 | 51 | 4 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Proliferating-Cycling|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.04e-05 | 200 | 51 | 4 | d582385b2dbb25eeba1b22c5d258a8f26a40ef8b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.04e-05 | 200 | 51 | 4 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.34e-04 | 118 | 51 | 3 | bc65345ee8e59fbda60f345696192376cdbf54b8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.54e-04 | 131 | 51 | 3 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.85e-04 | 134 | 51 | 3 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 5.06e-04 | 136 | 51 | 3 | f024015bf60e64b8657e410e24995a1edec85196 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-04 | 142 | 51 | 3 | 67d4ff3483ae34f77c3325aa0fbd3462ca19ade4 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.74e-04 | 142 | 51 | 3 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-04 | 148 | 51 | 3 | bbf4933582b50b3412c805de5ed137107c996236 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-04 | 148 | 51 | 3 | 6543860e3207a7de92a35bb6004be51287582f7a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-04 | 148 | 51 | 3 | 79e376503a3f9504a1ec5af4a60a09cc80e19059 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-04 | 149 | 51 | 3 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.12e-04 | 153 | 51 | 3 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.12e-04 | 153 | 51 | 3 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.12e-04 | 153 | 51 | 3 | 92a5307b8e4dcf9ee42134b4c0645f9d488df61a | |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 7.26e-04 | 154 | 51 | 3 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.40e-04 | 155 | 51 | 3 | 93bfcf5c12cbb61a1e0444312afd2aa411a8bf50 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-04 | 155 | 51 | 3 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-04 | 156 | 51 | 3 | 955547dfeb1b1ad4957b4338701055726b22619f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.68e-04 | 157 | 51 | 3 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.96e-04 | 159 | 51 | 3 | e9c51e611ebd427bbe51e3e036c14122c36ea372 | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 8.26e-04 | 161 | 51 | 3 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-04 | 162 | 51 | 3 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-04 | 162 | 51 | 3 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-04 | 163 | 51 | 3 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.56e-04 | 163 | 51 | 3 | 466c8129852a5b16cd9fcc6b79e799abc21bb21a | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-04 | 163 | 51 | 3 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.56e-04 | 163 | 51 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-04 | 163 | 51 | 3 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-04 | 165 | 51 | 3 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.86e-04 | 165 | 51 | 3 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-04 | 166 | 51 | 3 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 9.02e-04 | 166 | 51 | 3 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-04 | 167 | 51 | 3 | e0f2509e86302eca8352821bce12597f6c51fc24 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-04 | 167 | 51 | 3 | b25646b6653cd8814dbeae4c74ce899ede105200 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.34e-04 | 168 | 51 | 3 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.34e-04 | 168 | 51 | 3 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-04 | 168 | 51 | 3 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 9.50e-04 | 169 | 51 | 3 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-04 | 169 | 51 | 3 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.93e-07 | 195 | 52 | 7 | 3663_DN | |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; HL60; HT_HG-U133A | 4.34e-06 | 188 | 52 | 6 | 2161_DN | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; HL60; HT_HG-U133A | 4.62e-06 | 190 | 52 | 6 | 3144_DN | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 5.21e-06 | 194 | 52 | 6 | 7189_UP | |
| Drug | cyanogen chloride | 3.06e-05 | 4 | 52 | 2 | CID000010477 | |
| Drug | ascididemin | 5.09e-05 | 5 | 52 | 2 | CID000189219 | |
| Drug | 1,4-anthraquinone | 5.09e-05 | 5 | 52 | 2 | ctd:C416442 | |
| Drug | 6(hydroxymethyl)-1,4-anthracenedione | 5.09e-05 | 5 | 52 | 2 | ctd:C530630 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.62e-05 | 180 | 52 | 5 | 4541_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.92e-05 | 182 | 52 | 5 | 3887_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.24e-05 | 184 | 52 | 5 | 2321_DN | |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 6.24e-05 | 184 | 52 | 5 | 1344_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; HL60; HG-U133A | 6.56e-05 | 186 | 52 | 5 | 1555_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 6.73e-05 | 187 | 52 | 5 | 4323_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | 7.08e-05 | 189 | 52 | 5 | 6750_DN | |
| Drug | Benzbromarone [3562-84-3]; Up 200; 9.4uM; HL60; HT_HG-U133A | 7.08e-05 | 189 | 52 | 5 | 1291_UP | |
| Drug | Polyphenols | 7.18e-05 | 452 | 52 | 7 | ctd:D059808 | |
| Drug | Securinine [5610-40-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 7.63e-05 | 192 | 52 | 5 | 3470_UP | |
| Drug | gardenin B | 7.63e-05 | 6 | 52 | 2 | ctd:C000591222 | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 7.82e-05 | 193 | 52 | 5 | 3562_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 2068_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 2655_DN | |
| Drug | ST021200; Down 200; 10uM; PC3; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 7493_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 3217_DN | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; HL60; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 2351_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 1820_UP | |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 7139_DN | |
| Drug | Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 7345_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 2362_DN | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; MCF7; HT_HG-U133A_EA | 8.82e-05 | 198 | 52 | 5 | 881_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 1831_DN | |
| Drug | Ginkgolide A [15291-75-5]; Down 200; 9.8uM; PC3; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 4002_DN | |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; PC3; HG-U133A | 9.03e-05 | 199 | 52 | 5 | 1957_UP | |
| Drug | Podophyllotoxin | 1.07e-04 | 7 | 52 | 2 | ctd:D011034 | |
| Drug | 7-hydroxystaurosporine | 1.13e-04 | 41 | 52 | 3 | ctd:C054852 | |
| Drug | 1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one | 1.30e-04 | 43 | 52 | 3 | ctd:C569107 | |
| Drug | quinoline-val-asp(OMe)-CH2-OPH | 1.42e-04 | 8 | 52 | 2 | ctd:C468548 | |
| Drug | dichloroacetonitrile | 1.42e-04 | 8 | 52 | 2 | CID000018177 | |
| Drug | trichloroacetonitrile | 1.82e-04 | 9 | 52 | 2 | CID000011011 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 3.77e-04 | 17 | 50 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Ovarian Serous Adenocarcinoma | 6.96e-04 | 23 | 50 | 2 | C1335177 | |
| Disease | erythrocyte measurement | 9.45e-04 | 257 | 50 | 4 | EFO_0005047 | |
| Disease | indole-3-propionate measurement | 9.61e-04 | 27 | 50 | 2 | EFO_0010501 | |
| Disease | Lung Neoplasms | 1.06e-03 | 265 | 50 | 4 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.07e-03 | 266 | 50 | 4 | C0242379 | |
| Disease | Bilateral Wilms Tumor | 1.11e-03 | 29 | 50 | 2 | C2930471 | |
| Disease | Strabismus | 1.11e-03 | 29 | 50 | 2 | HP_0000486 | |
| Disease | Breast Cancer, Familial | 1.19e-03 | 30 | 50 | 2 | C0346153 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 1.64e-03 | 137 | 50 | 3 | EFO_0007795, EFO_0010724 | |
| Disease | Nephroblastoma | 1.71e-03 | 36 | 50 | 2 | C0027708 | |
| Disease | colorectal carcinoma (is_marker_for) | 1.80e-03 | 37 | 50 | 2 | DOID:0080199 (is_marker_for) | |
| Disease | cataract (implicated_via_orthology) | 1.90e-03 | 38 | 50 | 2 | DOID:83 (implicated_via_orthology) | |
| Disease | immature reticulocyte measurement | 2.11e-03 | 40 | 50 | 2 | EFO_0803545 | |
| Disease | mean reticulocyte volume | 2.23e-03 | 799 | 50 | 6 | EFO_0010701 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FMCNAPASPINDKEK | 26 | Q8N814 | |
| KFMLKEKPPNENCNN | 766 | Q96JP9 | |
| IKQLQNPDMALCPHF | 311 | Q8N336 | |
| NDNQETAAMKPANLK | 266 | Q8IVF6 | |
| QFQFMNKKTQPHPLE | 511 | A4D0V7 | |
| NEKDPDNKNLCVQMF | 216 | P49760 | |
| PPQKKEDDFLNNAMS | 191 | Q8N6T3 | |
| QLNHIKDEKSNPTPM | 1111 | P78312 | |
| KPCKNLMNTLNNLHQ | 511 | Q7Z401 | |
| AKQQQLAASPPDSKM | 666 | P49796 | |
| NKKNAAVMDQEPAGN | 271 | P43631 | |
| MKKPPLLNNADSVQA | 746 | P09874 | |
| HMKNQALFPACVLKN | 221 | Q92499 | |
| NKKNAAVMDQEPAGN | 366 | P43629 | |
| PCLHKPNNNDIDMNL | 376 | Q14651 | |
| NHAMKPINDNKEPLN | 671 | P16284 | |
| DFQNKHPNMCRLSPD | 346 | Q8TAT6 | |
| NAKFPAPMDKNLNEL | 2431 | Q6ZR08 | |
| AQNPNCNIMIFHPTK | 11 | Q6B0I6 | |
| PAQSFLMNKNQVPKL | 476 | P78344 | |
| QKQVNDHPPEQCGMF | 106 | O95613 | |
| NHPSNKVKSDPQRMN | 261 | Q9UBB5 | |
| KLPNKNDPNYLCMEA | 136 | Q9ULW2 | |
| MKTNNQDHNGNIPKP | 361 | O00716 | |
| TAAPKCKEMQNSLNN | 1586 | P51587 | |
| EMKPQTSPACQDHNK | 306 | Q6ZN84 | |
| HSPKKNPEDQTMPQN | 61 | Q96PZ2 | |
| LPKNTPCLNAQEQFM | 531 | Q17RS7 | |
| PSPQACNSAMKNINK | 46 | Q9H1E1 | |
| DNANCPSLQNKPKMF | 301 | P42575 | |
| PSLQNKPKMFFIQAC | 306 | P42575 | |
| PPQSKLLREDKNHNM | 246 | Q02241 | |
| PKEKDSPHMQDPNQA | 321 | P23511 | |
| SNLKEKMNAPNQPPH | 111 | Q9Y6R4 | |
| MQKDPQALSEHLKNP | 511 | P31948 | |
| QPQEKLCKNPCAMFA | 1091 | O95425 | |
| EMKNSCNVLHPQSPN | 1651 | Q7Z333 | |
| DMSALNNLFGPQKPK | 836 | Q6P3W7 | |
| KHRNENTCPLPQEMK | 126 | Q96T21 | |
| VPAAQQMLNFPEKNK | 576 | Q92922 | |
| FSPEEMKQLNALNKN | 281 | P14550 | |
| SPFLMAKPQKDEKNN | 156 | Q9Y271 | |
| IPMADPINKNHKCYN | 301 | Q01973 | |
| MAAHRPGPLKQQNKA | 1 | Q2NL82 | |
| MNHKEKFENLGIQPP | 206 | P17980 | |
| QCHKPQQQAPAMKTN | 626 | Q92576 | |
| DGMPPNLKNLSLAKN | 671 | Q9NYK1 | |
| NPATEMSKQNPAANK | 241 | Q6P444 | |
| SQPPEKQQAMHLCFE | 1026 | Q9UIA9 | |
| NMKALNYNENLPKHP | 231 | Q9Y2H8 | |
| QDICNSKHMQKNPPG | 216 | Q7Z2W4 | |
| LMEPPFQNQKKFGTN | 191 | O14530 | |
| NPFHCNILMKDDKDP | 1311 | Q96QT4 | |
| DKKGNNANPEANMNI | 21 | Q5VXJ0 |